Overview. Terpenes contribute to the aroma and chemical profile of cannabis, but they are volatile, oxidation-prone and sensitive to sampling and storage. Terpene testing can support product characterisation, stability and process understanding, provided the method and claims are appropriately controlled.
Purpose of terpene testing
The intended use should be defined. Terpene results may support identity, chemotype characterisation, process comparison, stability trending or formulation control. They should not automatically be converted into therapeutic claims.
Sampling and volatile loss
Grinding, heat, open containers and long hold times can reduce measured concentrations. Sample handling should minimise evaporation and oxidation.
Analytical approaches
Headspace GC-FID or GC-MS is commonly used. Direct injection may be appropriate for selected matrices but can increase contamination and carryover.
Identification
Retention time, retention indices, mass spectra and reference standards may be used together. Library matches alone can be unreliable for structurally similar terpenes.
Calibration and quantification
Authentic standards are preferred. Internal standards can improve precision, but response factors may vary between terpenes.
Stability and packaging
Terpene loss may reflect package permeability, headspace, storage temperature, light or repeated opening. Stability studies should distinguish true degradation from analytical variability.
Interpretation and claims
A terpene profile is a chemical measurement. Claims about clinical effect require separate evidence.
Practical reference table
| Risk | Effect on result | Control |
|---|---|---|
| Open sample handling | Volatile loss | Closed preparation and short hold time |
| Oxidation | Changed profile | Light/oxygen control |
| Co-elution | Biased identity | Optimised column and MS confirmation |
| Unstable standards | Calibration drift | Controlled storage and expiry |
| Packaging permeability | Shelf-life loss | Barrier and stability assessment |
Control and decision path
Frequently asked questions
Why are terpene results variable?
Volatility, sampling, oxidation and matrix differences can all affect results.
Is GC-MS better than GC-FID?
GC-MS provides stronger identification, while GC-FID can be robust for routine quantification.
Can terpene profiles prove clinical efficacy?
No. Chemical composition and therapeutic effect are separate questions.
Should flower be ground before testing?
Only under a controlled method that minimises volatile loss and remains representative.
Why include terpenes in stability studies?
They may decline through evaporation, oxidation or packaging loss.
Primary references and guidance
- ICH Q2(R2)
- ICH Q14
- European Pharmacopoeia 2.2.28
- EU GMP Part I, Chapter 6
- ISO 17025
- Relevant validated GC methods
- European Pharmacopoeia, Cannabis flower
Confirm the current effective revision and national applicability before operational or regulatory use.